Tara Bancroft
Stock Analyst at TD Cowen
(2.59)
# 1,999
Out of 4,818 analysts
8
Total ratings
50%
Success rate
22.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $39.49 | +26.61% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $46.20 | +40.69% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $7.85 | +40.22% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.39 | +622.02% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $41.90 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $8.70 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $39.49
Upside: +26.61%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $46.20
Upside: +40.69%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $7.85
Upside: +40.22%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.39
Upside: +622.02%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $41.90
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $8.70
Upside: -